Discover
AIDX
20/20 Biolabs, Inc.
0.58
1 x 0.58
3 x 0.60
bid
ask
+
0.00
0.85%
1 @ 06:30 AM
0.55 -0.03 (5.66%)
| Ytd | -97.56% | |
| 1y | -97.56% |
0.55
day range
0.62
0.50
52 week range
50.00
| Open | 0.58 | Prev Close | 0.58 | Low | 0.55 | High | 0.62 | Mkt Cap | 7.14M |
| Vol | 229.78K | Avg Vol | 792.08K | EPS | N/A | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.01 | 200-d Avg | 2.12 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 353.38K | ||
| Revenues (USD) | 353.38K | ||
| Cost of Revenue | 290.49K | ||
| Gross Profit | 62.88K | ||
| Operating Expenses | 1.51M | ||
| Research and Development Expense | 153.48K | ||
| Selling, General and Administrative Expense | 1.35M | ||
| Operating Income | -1.44M | ||
| Interest Expense | 267.01K | ||
| Net Income | -2.17M | ||
| Net Income Common Stock | -2.12M | ||
| Net Income Common Stock (USD) | -2.12M | ||
| Consolidated Income | -2.17M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -1.91M | ||
| Earning Before Interest & Taxes (USD) | -1.91M | ||
| Preferred Dividends Income Statement Impact | -54.19K | ||
| Weighted Average Shares | 7.66M | ||
| Weighted Average Shares Diluted | 7.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.22M | ||
| Cash and Equivalents (USD) | 4.22M | ||
| Trade and Non-Trade Receivables | 201.48K | ||
| Current Assets | 4.70M | ||
| Property, Plant & Equipment Net | 607.69K | ||
| Total Assets | 5.80M | ||
| Debt Current | 496.37K | ||
| Total Debt | 925.49K | ||
| Current Liabilities | 2.58M | ||
| Debt Non-Current | 429.12K | ||
| Total Liabilities | 3.05M | ||
| Accumulated Retained Earnings (Deficit) | -35.42M | ||
| Shareholders Equity | 2.55M | ||
| Shareholders Equity (USD) | 2.55M | ||
| Assets Non-Current | 1.10M | ||
| Total Debt (USD) | 925.49K | ||
| Deferred Revenue | 487.72K | ||
| Goodwill and Intangible Assets | 472.32K | ||
| Inventory | 104.52K | ||
| Liabilities Non-Current | 466.18K | ||
| Trade and Non-Trade Payables | 980.49K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.81K | ||
| Net Cash Flow from Financing | 4.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.19M | ||
| Issuance (Repayment) of Debt Securities | 250.00K | ||
| Net Cash Flow from Investing | -5.35K | ||
| Net Cash Flow from Operations | -1.29M | ||
| Share Based Compensation | 128.44K | ||